➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
AstraZeneca
Boehringer Ingelheim
Merck
Harvard Business School

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Technetium tc-99m exametazime kit - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for technetium tc-99m exametazime kit and what is the scope of patent protection?

Technetium tc-99m exametazime kit is the generic ingredient in two branded drugs marketed by Ge Healthcare and Jubilant Draximage, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m exametazime kit. Four suppliers are listed for this compound.

Summary for technetium tc-99m exametazime kit
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 4
Suppliers / Packagers: 4
DailyMed Link:technetium tc-99m exametazime kit at DailyMed
Pharmacology for technetium tc-99m exametazime kit

US Patents and Regulatory Information for technetium tc-99m exametazime kit

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Draximage DRAX EXAMETAZIME technetium tc-99m exametazime kit POWDER;INTRAVENOUS 208870-001 Aug 17, 2017 RX No No   Start Trial   Start Trial   Start Trial
Ge Healthcare CERETEC technetium tc-99m exametazime kit INJECTABLE;INJECTION 019829-001 Dec 30, 1988 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for technetium tc-99m exametazime kit

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Healthcare CERETEC technetium tc-99m exametazime kit INJECTABLE;INJECTION 019829-001 Dec 30, 1988   Start Trial   Start Trial
Ge Healthcare CERETEC technetium tc-99m exametazime kit INJECTABLE;INJECTION 019829-001 Dec 30, 1988   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Colorcon
Dow
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.